NCT02493595

Brief Summary

The study will seek to understand the effective use of a novel Microwave Radar Breast Imaging System in a Symptomatic Breast Care Clinic. The MARIA Imaging system uses low level non--ionising radiation (radio wave) signals to scan the breast tissue volume and to provide a visual image of areas of varying tissue permittivity value within the volume. These areas of varying permittivity can be shown as a two or three dimensional image and used in conjunction with the X-Ray mammogram and ultrasound scans to provide another level of diagnosis to the radiologist.The system works equally well in both dense and lucent breast types and can in particular provide insight into the diagnosis in dense tissue cases. The trial will accept symptomatic cases with suspected cancer, cysts or fibroadenoma. The trial will use the images produced by the MARIA system and compare them to the images obtained using X-Ray mammography. The results of the comparison will be assessed to understand the effectiveness of the MARIA image in assisting with the identification and location of suspected lesions for further specific analysis using Ultrasound/Biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
264

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

April 14, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 9, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 17, 2018

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

April 14, 2015

Last Update Submit

August 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity of Radio-Wave imaging in the diagnostic breast care clinic

    The research will seek to measure the added value of a radiowave imaging procedure in a diagnostic breast care clinic in improving accuracy of diagnostic outcomes. In particular it will evaluate the ability of radiowave imaging in the younger patient to demonstrate the presence of lesions in tissue which is dense. As a nonionizing radiation it also has potential to be the bulk imaging method of choice in women under 40 who would only be offered a mammogram where the risk benefit justified it, i.e. with a probability of malignancy.

    Duration of the Study, 6 month interval progress assessment

Secondary Outcomes (1)

  • Comparison of radio wave image sensitivity in Dense Tissue BIRADS c and d as compared to X-Ray Mammography

    Study result assessed every 6 months

Study Arms (1)

Cancer

Patients attending One-stop Symptomatic Breast Care clinics with suspicion of a breast lesion in one or both breasts.

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female Patients with suspicion of breast lesions attending One-Stop Breast Care diagnostic clinics

You may qualify if:

  • Referred for diagnosis because of a reported symptom of breast disease
  • No previous treatment or biopsy
  • Breast size 32A to breast size 42DD
  • Able to lie prone on a couch for 10 minutes
  • Able to remain reasonably still for 2 minutes

You may not qualify if:

  • Breast implants
  • Recent Biopsy
  • Extremely small or extremely large breasts
  • Presence of metal or blood lesion (haematoma)
  • Breathlessness or severe arthritis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Bristol Trust NHS Breast Care Clinic

Bristol, BS10 5NB, United Kingdom

Location

Study Officials

  • Michael H Shere, M.R.C.S

    North Bristol NHS Trust, United Kingdom

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 14, 2015

First Posted

July 9, 2015

Study Start

April 1, 2015

Primary Completion

March 1, 2017

Study Completion

August 1, 2018

Last Updated

August 17, 2018

Record last verified: 2018-08

Locations